Breese_2000_Neuropsychopharmacology_23_351

Reference

Title : Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia - Breese_2000_Neuropsychopharmacology_23_351
Author(s) : Breese CR , Lee MJ , Adams CE , Sullivan B , Logel J , Gillen KM , Marks MJ , Collins AC , Leonard S
Ref : Neuropsychopharmacology , 23 :351 , 2000
Abstract : Previous studies have suggested that an abnormality in neuronal nicotinic acetylcholine receptor expression or function may be involved in the neuropathophysiology of schizophrenia. [(3)H]-nicotine and [(3)H]-epibatidine binding were compared in postmortem brain from control and schizophrenic subjects with varying smoking histories. In control subjects, increased receptor binding was seen in hippocampus, cortex, and caudate with increasing tobacco use. In contrast, schizophrenic smokers had reduced nicotinic receptor levels in these brain regions compared to control smokers. Chronic haloperidol and nicotine treatment, in the rat, was used to assess neuroleptic effects on receptor up-regulation by nicotine. A significant increase in cortical nicotinic receptors was seen in both nicotine treated as well as haloperidol and nicotine co-treated animals, suggesting that the abnormal regulation of high affinity neuronal nicotinic receptors in schizophrenics following nicotine use was not related to chronic neuroleptic treatment.
ESTHER : Breese_2000_Neuropsychopharmacology_23_351
PubMedSearch : Breese_2000_Neuropsychopharmacology_23_351
PubMedID: 10989262

Related information

Citations formats

Breese CR, Lee MJ, Adams CE, Sullivan B, Logel J, Gillen KM, Marks MJ, Collins AC, Leonard S (2000)
Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia
Neuropsychopharmacology 23 :351

Breese CR, Lee MJ, Adams CE, Sullivan B, Logel J, Gillen KM, Marks MJ, Collins AC, Leonard S (2000)
Neuropsychopharmacology 23 :351